Gaviscon

Package leaflet: Information for the user

GAVISCON 500 mg/10 ml + 267 mg/10 ml oral suspension, 500 mg/10 ml + 267 mg/10 ml peppermint flavoured oral suspension

Sodium alginate + sodium bicarbonate
Please read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you to do.
Keep this leaflet. You may need to read it again.
If you need more information or advice, consult your pharmacist.
If you experience any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. See section 4.
Talk to your doctor if you do not notice improvement or if you notice worsening of symptoms after 7 days.

Contents of this leaflet:

1. What GAVISCON is and what it is used for
2. What you need to know before taking GAVISCON
3. How to take GAVISCON
4. Possible side effects
5. How to store GAVISCON
6. Contents of the pack and other information

1. What GAVISCON is and what it is used for

Gaviscon is a medicine belonging to the class of drugs used for the treatment of peptic ulcer (a lesion affecting the inner lining of the stomach) and gastro-oesophageal reflux (a condition occurring when the acidic contents of the stomach flow back up into the throat and oesophagus).
Gaviscon is indicated in adults and adolescents (12 – 18 years) and works by relieving symptoms of occasional heartburn.

2. What you need to know before taking GAVISCON

Do not take Gaviscon

• If you are allergic to sodium alginate or sodium bicarbonate or to any of the other ingredients of this medicine (listed in section 6), including methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) (parabens).

Warnings and precautions
Talk to your doctor or pharmacist before taking Gaviscon.
In particular, inform your doctor or pharmacist if:

• You suffer or have previously suffered from kidney disorder impairing kidney function (renal insufficiency).

Do not take this medicine for prolonged treatment. If symptoms persist beyond 7 days from the start of treatment, consult your doctor.
Children and adolescents
In adolescents (12–18 years of age), use only when strictly necessary and under close medical supervision.
Other medicines and Gaviscon
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Leave at least 2 hours between taking Gaviscon and other medicines, especially if they belong to the following classes:

• Tetracyclines, fluoroquinolones (medicines used to treat bacterial infections, antibiotics),
• Iron salts (medicines used in the treatment of anaemia),
• Thyroid hormones (medicines used in the treatment of hypothyroidism and thyroid gland enlargement),
• Chloroquine (a medicine used to treat malaria),
• Bisphosphonates (medicines used to treat certain bone diseases),
• Estramustine (a medicine used to treat prostate cancer).

Pregnancy, breastfeeding and fertility
If you are pregnant, think you may be pregnant, are planning to become pregnant, or are breastfeeding, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
During pregnancy, Gaviscon may be used after consulting your doctor, as your doctor must evaluate the expected benefits against any potential risks to you or the foetus.
Breastfeeding:
Gaviscon may be used during breastfeeding, after consulting your doctor.
Fertility:
Preclinical and clinical data suggest that Gaviscon has no effect on human fertility.
Driving and using machines
Gaviscon does not impair the ability to drive or use machinery.
Gaviscon contains sodium, calcium carbonate, methyl parahydroxybenzoate, propyl parahydroxybenzoate and
benzyl alcohol
Sodium: This medicine contains 142.6 mg of sodium (the main component of table salt) per 10 ml of suspension. This corresponds to approximately 7% of the maximum recommended daily dietary intake for an adult. Speak with your doctor or pharmacist if you need to take 20 ml of suspension or more doses per day over a prolonged period, especially if you have impaired kidney function or are on a low-sodium diet.
Calcium carbonate: Each 10 ml dose of suspension contains 160 mg of calcium carbonate. Consult your doctor or pharmacist if you have hypercalcaemia, nephrocalcinosis, or recurrent calcium-containing kidney stones.
Methyl parahydroxybenzoate and propyl parahydroxybenzoate: 10 ml of suspension contains 40 mg of methyl parahydroxybenzoate and 6 mg of propyl parahydroxybenzoate, which may cause allergic reactions (including delayed reactions).
Benzyl alcohol: GAVISCON 500 mg/10 ml + 267 mg/10 ml oral suspension contains a fennel flavour, which in turn contains benzyl alcohol (1.1 mg per 10 ml dose). Benzyl alcohol may cause allergic reactions. Ask your doctor or pharmacist for advice if you are pregnant or breastfeeding, or if you have liver or kidney disease. This is because large amounts of benzyl alcohol may accumulate in the body and cause unwanted effects (such as metabolic acidosis).

3. How to take GAVISCON

Take this medicine exactly as stated in this leaflet or as instructed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.

Adults and adolescents (12–18 years)
Take 10–20 ml (second to fourth mark on the measuring spoon, or 2–4 dosing spoons, or 1–2 single-dose sachets) after meals and in the evening before going to bed.

Warning: Do not exceed the recommended doses without medical advice.
Shake the suspension well before use.

If you suffer or have previously suffered from kidney disorder impairing kidney function (renal insufficiency), inform your doctor.

Use Gaviscon only for short-term treatment. Consult your doctor if symptoms worsen or do not improve within 7 days of treatment, if the condition recurs repeatedly, or if you notice any recent change in symptom pattern.

If you take more Gaviscon than you should
Symptoms
In case of accidental ingestion or overdose of Gaviscon, you may experience abdominal bloating.

Treatment
Contact your doctor immediately, who will initiate appropriate supportive treatment, or go to the nearest hospital.

If you forget to take Gaviscon
Do not take a double dose to make up for the missed dose.

If you stop taking Gaviscon
If you have any questions about the use of this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The side effects are listed below according to their frequency of occurrence:

Very rare (may affect up to 1 in 10,000 people)

• allergic reactions, including severe reactions (anaphylactic or anaphylactoid reactions)
• hypersensitivity reactions that may manifest as skin redness accompanied by itching (urticaria)
• breathing difficulties (bronchospasm)
• increased gas formation in the stomach and intestine (flatulence), nausea
• swelling (edema)

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist.
You may also report side effects directly through the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse . By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store GAVISCON

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after "Expiry". The expiry date refers to the last day of that month.
Do not use this medicine if you notice any signs of deterioration.

• Oral suspension and peppermint-flavoured oral suspension in bottle Store in the original packaging. Do not store above 30°C. Do not refrigerate.
• Peppermint-flavoured oral suspension in sachets Store in the original packaging. Do not store above 25°C. Do not refrigerate.

Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.

6. Pack contents and other information

What Gaviscon contains
Gaviscon 500 mg/10 ml + 267 mg/10 ml oral suspension

• The active substances are: sodium alginate, sodium bicarbonate (10 ml of suspension contain 500 mg of sodium alginate and 267 mg of sodium bicarbonate) (see section 2).
• The other components are: carbomers, calcium carbonate, methyl p-hydroxybenzoate (E218), propyl p-hydroxybenzoate (E216), sodium hydroxide, sodium saccharin, fennel flavour (containing benzyl alcohol), erythrosine, purified water (see section 2).

Gaviscon 500 mg/10 ml + 267 mg/10 ml oral suspension, peppermint flavour

• The active substances are: sodium alginate, sodium bicarbonate (10 ml of suspension contain 500 mg of sodium alginate and 267 mg of sodium bicarbonate) (see section 2).
• The other components are: carbomers, calcium carbonate, methyl p-hydroxybenzoate (E218), propyl p-hydroxybenzoate (E216), sodium hydroxide, sodium saccharin, peppermint flavour, purified water (see section 2).

Description of the appearance of Gaviscon and contents of the pack
Oral suspension
Gaviscon is an oral suspension.
Gaviscon is available in a pack containing 1 bottle of 200 ml oral suspension and 1 measuring spoon graduated at 5, 10, 15 and 20 ml, or 1 dosing spoon of 5 ml.
Peppermint-flavoured oral suspension
Gaviscon is an oral suspension with peppermint flavour.
Gaviscon is available in packs containing:

• 1 bottle of 200 ml, 300 ml or 500 ml of oral suspension, or
• 12, 20 or 24 single-dose sachets of 10 ml oral suspension.

Not all pack sizes may be marketed.

Marketing Authorisation Holder
Reckitt Benckiser Healthcare (Italia) S.p.A., via G. Spadolini 7, 20141 Milano
Manufacturer:
Reckitt Benckiser Healthcare (UK) Limited, Dansom Lane, Hull, HU8 7DS, East Yorkshire, (United Kingdom)
RB NL Brands B.V., Schiphol Boulevard 207, Schiphol 1118BH, Netherlands

Package leaflet: Information for the user

GAVISCON 250 mg + 133.5 mg chewable tablets, peppermint flavour; 250 mg + 133.5 mg chewable tablets, strawberry flavour

Sodium alginate + sodium bicarbonate
Please read this leaflet carefully before taking this medicine because it contains important
information for you.
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you to do.
Keep this leaflet. You may need to read it again.
If you need more advice or information, consult your pharmacist.
If you experience any side effects, including any not listed in this leaflet, consult your doctor or pharmacist. See section 4.
Consult your doctor if you do not notice any improvement or if your symptoms worsen after 7 days.
Contents of this leaflet:

1. What GAVISCON is and what it is used for
2. What you need to know before taking GAVISCON
3. How to take GAVISCON
4. Possible side effects
5. How to store GAVISCON
6. Contents of the pack and other information

1. What GAVISCON is and what it is used for

Gaviscon is a medicine that belongs to the class of drugs used for the treatment of peptic ulcer (a lesion affecting the inner lining of the stomach) and gastroesophageal reflux (a condition occurring when the acidic contents of the stomach flow back up into the throat and esophagus).
Gaviscon is indicated in adults and adolescents (12–18 years) and works by relieving symptoms of occasional heartburn.

2. What you need to know before taking GAVISCON

Do not take Gaviscon

• If you are allergic to sodium alginate or sodium bicarbonate, or to any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions
Talk to your doctor or pharmacist before taking Gaviscon.
In particular, inform your doctor or pharmacist if:

• You suffer or have previously suffered from kidney disorder impairing kidney function (renal insufficiency).

Do not take this medicine for prolonged treatments. If symptoms persist beyond 7 days from the start of treatment, consult your doctor.
Children and adolescents
In adolescents (12–18 years of age), use only when clearly necessary and under strict medical supervision.
Other medicines and Gaviscon
Inform your doctor or pharmacist if you are currently taking, have recently taken, or might take any other medicines.
Leave at least 2 hours between taking Gaviscon and taking other medicines, especially those belonging to the following classes:

• Tetracyclines, fluoroquinolones (medicines used to treat bacterial infections, antibiotics),
• Iron salts (medicines used in the treatment of anaemia),
• Thyroid hormones (medicines used in the treatment of hypothyroidism and thyroid gland enlargement),
• Chloroquine (a medicine used to treat malaria),
• Bisphosphonates (medicines used to treat certain bone diseases),
• Estramustine (a medicine used to treat prostate cancer).

Pregnancy, breastfeeding and fertility
If you are pregnant, think you may be pregnant, are planning to become pregnant, or are breastfeeding, consult your doctor or pharmacist before taking this medicine.
Pregnancy
Gaviscon may be used during pregnancy after consulting your doctor, as your doctor must evaluate the expected benefits against any potential risks for you and the foetus.
Breastfeeding
Gaviscon may be used during breastfeeding after consulting your doctor.
Fertility
Preclinical and clinical data suggest that Gaviscon has no effect on human fertility.
Driving and using machines
Gaviscon does not affect the ability to drive or operate machinery.
Gaviscon contains sodium, calcium carbonate and aspartame
Sodium: This medicine contains 63.25 mg of sodium (a main component of table salt) per chewable tablet. This corresponds to approximately 3% of the recommended maximum daily dietary intake for an adult. Speak with your doctor or pharmacist if you need to take 6 tablets or more doses per day for a prolonged period, especially if you have impaired kidney function or are on a low-sodium diet.
Calcium carbonate: Each tablet contains 80 mg of calcium carbonate. Ask your doctor or pharmacist if you have hypercalcaemia, nephrocalcinosis, or recurrent calcium-containing kidney stones.
Aspartame: This medicine contains 8.8 mg of aspartame per strawberry-flavoured chewable tablet and 3.75 mg of aspartame per peppermint-flavoured chewable tablet. Aspartame is a source of phenylalanine. It may be harmful if you have phenylketonuria, a rare genetic disorder causing phenylalanine to accumulate because the body cannot properly eliminate it.

3. How to take GAVISCON

Take this medicine exactly as stated in this leaflet or as instructed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
Adults and adolescents (12–18 years)
Take 2–4 tablets after meals and in the evening before going to bed.
Warning: Do not exceed the recommended doses without medical advice.
Take the tablets orally, chewing them thoroughly (you may break them and chew them in small portions).
You may then drink a little water.
If you suffer, or have previously suffered, from a kidney disorder affecting kidney function (renal insufficiency), inform your doctor.
Use Gaviscon only for short-term treatment. Consult your doctor if symptoms worsen or do not improve after 7 days of treatment, if the condition recurs repeatedly, or if you notice any recent changes in its characteristics.
If you take more Gaviscon than you should
Symptoms
In case of accidental ingestion or overdose of Gaviscon, you may experience abdominal bloating.
Treatment
Seek immediate medical advice. Your doctor will provide appropriate supportive therapy, or go to the nearest hospital.
If you forget to take Gaviscon
Do not take a double dose to make up for the missed dose.
If you stop taking Gaviscon
If you have any doubts about using this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone experiences them.
The following is a list of side effects according to their frequency of occurrence:

Very rare (may affect up to 1 in 10,000 people)

• allergic reactions, even severe ones (anaphylactic or anaphylactoid reactions)
• hypersensitivity reactions that may manifest as skin redness accompanied by itching (urticaria)
• breathing difficulties (bronchospasm)
• increased gas formation in the stomach and intestine (flatulence), nausea
• swelling (edema)

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist.
You can also report side effects directly via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store GAVISCON

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after "Expiry". The expiry date refers to the last day of that month.
Do not use this medicine if you notice any signs of deterioration.

• Mint-flavour chewable tablets: Store in the original packaging. Do not store above 30°C.
• Strawberry-flavour chewable tablets: Store in the original packaging. Do not store above 25°C. Strawberry-flavour chewable tablets in container with press-and-turn cap:

After first opening the container, the medicine should be used within 6 months; after this period, any remaining medicine must be discarded.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.

6. Package contents and other information

What Gaviscon contains
Gaviscon 250 mg + 133.5 mg chewable tablets, peppermint flavour

• The active substances are: sodium alginate, sodium bicarbonate (1 chewable tablet with peppermint flavour contains 250 mg of sodium alginate and 133.5 mg of sodium bicarbonate) (see section 2).
• The other components are: mannitol (E421), magnesium stearate, copovidone, potassium acesulfame, polyethylene glycol 20,000, peppermint flavour, calcium carbonate, aspartame (E951) (see section 2).

Gaviscon 250 mg + 133.5 mg chewable tablets, strawberry flavour

• The active substances are: sodium alginate, sodium bicarbonate (1 chewable tablet with strawberry flavour contains 250 mg of sodium alginate and 133.5 mg of sodium bicarbonate) (see section 2).
• The other components are: xylitol, mannitol (E421), polyethylene glycol 20,000, strawberry flavour, magnesium stearate, red iron oxide (E172), calcium carbonate, aspartame (E951) (see section 2).

Description of the appearance of Gaviscon and contents of the pack
Chewable tablets, peppermint flavour
Gaviscon is presented as chewable tablets with a peppermint flavour.
Gaviscon is available in packs of 16, 24, 32 or 48 tablets contained in blisters.

Chewable tablets, strawberry flavour
Gaviscon is presented as chewable tablets with a strawberry flavour.
Gaviscon is available in:

• tablet containers containing 16 or 20 tablets; or
• packs of 16, 24, 32 or 48 tablets contained in blisters.

Not all pack sizes may be marketed.

Marketing Authorization Holder
Reckitt Benckiser Healthcare (Italia) S.p.A., via G. Spadolini 7, 20141 Milano, Italy

Manufacturer:
Reckitt Benckiser Healthcare (UK) Limited, Dansom Lane, Hull, HU8 7DS, East Yorkshire, (United Kingdom)
RB NL Brands B.V., Schiphol Boulevard 207, Schiphol 1118BH, Netherlands

Package leaflet: Information for the user

GAVISCON 500 mg + 267 mg Chewable Tablets, Peppermint Flavour

Sodium alginate + sodium bicarbonate
Please read this entire leaflet carefully before taking this medicine, as it contains important
information for you.
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has instructed.
Keep this leaflet. You may need to read it again.
If you need more information or advice, consult your pharmacist.
If you experience any side effects, including those not listed in this leaflet, contact your doctor or pharmacist. See section 4.
Contact your doctor if you do not notice any improvement or if your symptoms worsen after 7 days.
Contents of this leaflet:

1. What GAVISCON is and what it is used for
2. What you need to know before taking GAVISCON
3. How to take GAVISCON
4. Possible side effects
5. How to store GAVISCON
6. Contents of the pack and other information

1. What GAVISCON is and what it is used for

Gaviscon is a medicine belonging to the class of drugs used to treat peptic ulcer (a lesion affecting the inner lining of the stomach) and gastroesophageal reflux (a condition that occurs when the acidic contents of the stomach flow back up into the throat, the oesophagus).
Gaviscon is indicated in adults and adolescents (12–18 years) and works by relieving symptoms of occasional heartburn.

2. What you need to know before taking GAVISCON

Do not take Gaviscon

• If you are allergic to sodium alginate or sodium bicarbonate, or to any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions
Talk to your doctor or pharmacist before taking Gaviscon.
In particular, inform your doctor or pharmacist if:

• You suffer, or have previously suffered, from kidney disorder impairing kidney function (renal insufficiency).

Do not take this medicine for prolonged treatments. If symptoms persist beyond 7 days from the start of treatment, consult your doctor.
Children and adolescents
In adolescents (12–18 years of age), use only when strictly necessary and under close medical supervision.
Other medicines and Gaviscon
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Leave at least 2 hours between taking Gaviscon and taking other medicines, especially those belonging to the following classes:

• Tetracyclines, fluoroquinolones (medicines used to treat bacterial infections, antibiotics),
• Iron salts (medicines used in the treatment of anaemia),
• Thyroid hormones (medicines used in the treatment of hypothyroidism and thyroid gland enlargement),
• Chloroquine (a medicine used to treat malaria),
• Bisphosphonates (medicines used to treat certain bone diseases),
• Estramustine (a medicine used to treat prostate cancer).

Pregnancy, breastfeeding and fertility
If you are pregnant, think you might be pregnant, are planning a pregnancy, or are breastfeeding, consult your doctor or pharmacist before taking this medicine.
Pregnancy
During pregnancy, Gaviscon may be used after consulting your doctor, as your doctor must evaluate the expected benefits against any potential risks for you and the foetus.
Breastfeeding:
Gaviscon may be used during breastfeeding, after consulting your doctor.
Fertility:
Preclinical and clinical data suggest that Gaviscon has no effect on human fertility.
Driving and using machines
Gaviscon does not affect the ability to drive or operate machinery.
Gaviscon contains sodium, calcium carbonate and aspartame
Sodium: This medicine contains 126.5 mg of sodium (a main component of table salt) per chewable tablet. This is equivalent to approximately 6% of the maximum recommended daily dietary intake for an adult. Speak with your doctor or pharmacist if you need to take 3 tablets or more per day for a prolonged period, especially if you have reduced kidney function or are on a low-sodium diet.
Calcium carbonate: Each tablet contains 160 mg of calcium carbonate. Ask your doctor or pharmacist if you have hypercalcaemia, nephrocalcinosis, or recurrent kidney stones containing calcium.
Aspartame: This medicine contains 7.5 mg of aspartame per chewable tablet. Aspartame is a source of phenylalanine. It may be harmful if you have phenylketonuria, a rare genetic disorder causing phenylalanine to accumulate because the body cannot eliminate it properly.

3. How to take GAVISCON

Take this medicine exactly as stated in this leaflet or as instructed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
Adults and adolescents (12-18 years)
Take 1-2 tablets after meals and in the evening before going to bed.
Caution: Do not exceed the recommended doses without medical advice.
Take the tablets by mouth, chewing them thoroughly (you may break them and chew them in small pieces).
You may then drink a little water.
If you suffer or have previously suffered from a kidney disorder impairing kidney function (renal insufficiency), inform your doctor.
Use Gaviscon only for short-term treatment. Consult your doctor if symptoms worsen or do not improve after 7 days of treatment, if the condition recurs repeatedly, or if you notice any recent change in its characteristics.
If you take more Gaviscon than you should
Symptoms
In case of accidental ingestion/overdose of Gaviscon, you may experience abdominal bloating.
Treatment
Seek immediate medical advice. Your doctor will provide appropriate supportive treatment, or go to the nearest hospital.
If you forget to take Gaviscon
Do not take a double dose to make up for the missed dose.
If you stop taking Gaviscon
If you have any questions about using this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The following is a list of side effects, classified according to their frequency of occurrence:
Very rare (may affect up to 1 in 10,000 people)

• allergic reactions, even severe (anaphylactic or anaphylactoid reactions)
• hypersensitivity reactions that may manifest as skin redness accompanied by itching (urticaria)
• breathing difficulties (bronchospasm)
• increased gas formation in the stomach and intestine (flatulence), nausea
• swelling (edema)

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, please consult your doctor or pharmacist.
You may also report side effects directly through the national reporting system at the following address: https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store GAVISCON

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after “Expiry”. The expiry date refers to the last day of that month.
Do not use this medicine if you notice any signs of deterioration.
Store in the original packaging. Do not store above 30°C.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.

6. Package contents and other information

What Gaviscon contains

• The active substances are: sodium alginate, sodium bicarbonate (1 mint-flavoured chewable tablet contains 500 mg of sodium alginate and 267 mg of sodium bicarbonate) (see section 2).
• The other components are: mannitol (E421), magnesium stearate, copovidone, acesulfame potassium, macrogol 20,000, mint flavouring, calcium carbonate, aspartame (E951) (see section 2).

Description of the appearance of Gaviscon and package contents
Gaviscon is presented as mint-flavoured chewable tablets.
Gaviscon is available in packs of 24, 36, 40 or 48 tablets in blister packs.
Marketing Authorization Holder
Reckitt Benckiser Healthcare (Italia) S.p.A., via G. Spadolini 7, 20141 Milano
Manufacturer:
Reckitt Benckiser Healthcare (UK) Limited, Dansom Lane, Hull, HU8 7DS, East Yorkshire, (United Kingdom)
RB NL Brands B.V., Schiphol Boulevard 207, Schiphol 1118BH, Netherlands